EU approves Danish plan to put EUR 108m behind Bavarian Nordic's Covid-19 vaccine
The Danish state's plan to award EUR 108m to support phase III studies of Bavarian Nordic's covid-19 vaccine has been approved by the EU Commission.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
The EU Commission, which works alongside competition authorities from member states, announced on Monday that it will allow the Danish state to offer Bavarian Nordic EUR 108m to support the development of its Covid-19 vaccine.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
